Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | sodium:hydrogen exchanger 2 (nhe2) | 0.0191 | 0 | 0.5 |
Echinococcus granulosus | sodium:hydrogen exchanger | 0.0191 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) | 0.1033 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0191 | 0 | 0.5 |
Echinococcus granulosus | sodium:hydrogen exchanger | 0.0191 | 0 | 0.5 |
Loa Loa (eye worm) | sodium/hydrogen exchanger | 0.0191 | 0 | 0.5 |
Mycobacterium ulcerans | isocitrate lyase AceAb | 0.1033 | 1 | 0.5 |
Loa Loa (eye worm) | sodium/hydrogen exchanger 3 family protein | 0.0191 | 0 | 0.5 |
Mycobacterium ulcerans | isocitrate lyase Icl | 0.1033 | 1 | 0.5 |
Giardia lamblia | Sodium/hydrogen exchanger 3 | 0.0191 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) | 0.1033 | 1 | 0.5 |
Schistosoma mansoni | sodium/hydrogen exchanger | 0.0191 | 0 | 0.5 |
Echinococcus multilocularis | sodium:hydrogen exchanger 2 (nhe2) | 0.0191 | 0 | 0.5 |
Echinococcus multilocularis | sodium:hydrogen exchanger | 0.0191 | 0 | 0.5 |
Echinococcus multilocularis | sodium:hydrogen exchanger 2 (nhe2) | 0.0191 | 0 | 0.5 |
Brugia malayi | sodium/hydrogen exchanger 3 family protein | 0.0191 | 0 | 0.5 |
Schistosoma mansoni | sodium/hydrogen exchanger 2 (nhe2) | 0.0191 | 0 | 0.5 |
Onchocerca volvulus | Sodium\/hydrogen exchanger homolog | 0.0191 | 0 | 0.5 |
Echinococcus granulosus | sodium:hydrogen exchanger 2 nhe2 | 0.0191 | 0 | 0.5 |
Onchocerca volvulus | Sodium\/hydrogen exchanger homolog | 0.0191 | 0 | 0.5 |
Onchocerca volvulus | Sodium\/hydrogen exchanger homolog | 0.0191 | 0 | 0.5 |
Echinococcus granulosus | sodium:hydrogen exchanger 2 nhe2 | 0.0191 | 0 | 0.5 |
Mycobacterium tuberculosis | Isocitrate lyase Icl (isocitrase) (isocitratase) | 0.1033 | 1 | 0.5 |
Echinococcus multilocularis | sodium:hydrogen exchanger | 0.0191 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0191 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0191 | 0 | 0.5 |
Loa Loa (eye worm) | NHE-3 | 0.0191 | 0 | 0.5 |
Echinococcus granulosus | sodium:hydrogen exchanger 2 nhe2 | 0.0191 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.663 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.399 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.911 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.69 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.556 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.472 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.421 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.176 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.